Development of nanoliposome formulations for intratumoral application

Purpose of our thesis; it has been aimed to prepare injectable formulations of the chemotherapeutic agent, which is effective in cancer cells, into nanoliposomes and to develop an intratumorally effective treatment approach. This will ensure that both chemotherapeutic drugs are effective at lower doses, as well as the associated side effects and resistance to growth. The targets of our policy are; 1. The increase of treatment efficiency by penetration with chemotherapeutic agent loaded nanoliposome formulations 2. Intratumoral injection of nanoliposomes to ensure that the drug only acts in the desired region 3. Reduction of drug side effects 4. Providing a faster and more effective response in advanced and drug-resistant tumors 5 Prolongation of patient survival by avoiding the spread of cancer In the event that our studies are successful, an innovative formulation will be developed as an alternative to the conventional preparations currently being used in therapy. Thus, a lower dose, shorter time and more effective treatment option for patients will be offered.